Table 4.
Anti-NMDAR encephalitis (n = 15) | |||
---|---|---|---|
Before treatment | After treatment | P* value | |
CSF anti-NMDAR Abs positive (n, %) | 15 (100) | 12 (80) | 0.224P1 |
Sex (male: female) | 8:7 | 8:7 | – |
mRS (IQR) | 4 (3–5) | 2 (1–2) | 0.002P2 |
Hcy level (umol/L, IQR) | 10.73 (6.36–19.97) | 8.77 (2.57–12.30) | 0.004P3 |
CRP level (mg/L, IQR)a | 7 (0.65–13.45) | 1 (0.60–4.90) | 0.041P2 |
Anti-NMDAR, anti-N-Methyl-D-aspartate receptor; CSF, cerebrospinal fluid; Ab, antibody; Hcy, homocysteine; mRS, modified Rankin Scale; CRP, C-reactive protein; IQR, interquartile range. a, n = 13.
Chi-square test was used for testing the association of two binary variables. Paired t-test was used when comparing the Hcy levels before and after treatment, and paired Mann-Whitney U test (also known as Wilcoxon rank-sum test) was used when comparing mRS scores and CRP level before and after treatment. P* value: P1, Chi-square test; P2, paired Mann-Whitney U tests; P3, paired t-test.